Cited by 245Medication Adherence and ComplianceSchizophrenia research and treatmentMental Health Treatment and Access

The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.

A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders

Sendt, Kyra-Verena, Tracy, Derek Kenneth, Bhattacharyya, Sagnik·2015·Psychiatry Research

DOI 10.1016/j.psychres.2014.11.002

Open this paper in CoChat — free account

Abstract

Adherence to antipsychotics improves outcome in schizophrenia. There is a lack of consensus on which factors most influence adherence behaviour and methodological issues hinder interpretation of existing evidence. A rigorous systematic search designed to identify robustly implicated factors emerging from methodologically rigorous studies narrowed our search to 13 observational studies (total N=6235) relating to adherence, antipsychotics and schizophrenia. Studies varied significantly, with reported adherence rates ranging from 47.2% to 95%. Positive attitude to medication and illness insight were the only factors consistently associated with better adherence, while contradictory results were found for socio-demographic characteristics, symptom severity and side effects. Only distinct aspects of the therapeutic relationship and social support in younger patients were related to good adherence. Antipsychotic type or formulation and neurocognitive functioning did not appear to impact medication adherence. Despite greater methodological rigour in determining studies to include in the present systematic review, it remains difficult to guide clinicians in this vital area and most of the work discussed contained small sample sizes. Future research in this field should therefore prioritise prospective study designs over longer periods and larger samples in naturalistic settings, providing a more appropriate and clinically meaningful framework than widely used cross-sectional designs.

Integrity signals

Registry

Crossref · 10.1016/j.psychres.2014.11.002

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,369
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Adherence to medication.
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,399
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
Wechsler Adult Intelligence Scale-III
Ryan, J. J., & Lopez, S. J. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1185-4_2 · Cited by 3,680
The burden of oral disease: challenges to improving oral health in the 21st century.
Petersen, P. E. (2005) · Europe PMC (PubMed Central) · Cited by 3,575
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
Simpson, G. M., B., M., B., G., Angus, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,265
Scale for the Assessment of Negative Symptoms (SANS)*
(1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,710
Scale for Assessment of Positive Symptoms (SAPS) 1984
Andreasen, N. C. (1995) · Open Scholarship Institutional Repository (Washington University in St. Louis) · Cited by 2,423
Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness
Horne, R., & Weinman, J. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00057-4 · Cited by 2,201
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,179
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Scale for the Assessment of Negative Symptoms
Andreasen, N. C. (1982) · PsycTESTS Dataset · doi:10.1037/t12696-000 · Cited by 1,888
Social Class and Mental Illness: A Community Study
Hollingshead, A. B., & Redlich, F. C. (2007) · American Journal of Public Health · doi:10.2105/ajph.97.10.1756 · Cited by 1,846
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. (1984) · Schizophrenia Bulletin · doi:10.1093/schbul/10.3.388 · Cited by 1,693
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.07.045120 · Cited by 1,632
Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
Spitzer, R. L., & Williams, J. (1987) · Cited by 1,621
Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia: A Comprehensive Review of Recent Literature
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1007 · Cited by 1,383 · cited 19×
“Interestingly, even antipsychotic-induced side effects do not appear to reliably predict whether patients continue taking medication as prescribed (Lacro et al., 2002; Robinson et al., 2002; Fleischhacker et al., 2003; Marder, 2003; Perkins et al., 2008).”
BackgroundResultInfluential
Measurement of Premorbid Adjustment in Chronic Schizophrenia
Cannon-Spoor, H. E., Potkin, S. G., & Wyatt, R. J. (1982) · Schizophrenia Bulletin · doi:10.1093/schbul/8.3.470 · Cited by 1,220
Insight and Psychosis
David, A. S. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.156.6.798 · Cited by 1,183
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia
Jones, P. B., Barnes, T. R. E., Davies, L. M., Dunn, G., Lloyd, H. M., Hayhurst, K. P., Murray, R. M., Markwick, A., & Lewis, S. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1079 · Cited by 1,112
Assessment of insight in psychosis
AMADOR, X. F., Strauss, D. H., Yale, S. A., FLAUM, M. M., Endicott, J., & Gorman, J. M. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.873 · Cited by 1,100
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
A quality of life interview for the chronically mentally ill
Lehman, A. F. (1988) · Evaluation and Program Planning · doi:10.1016/0149-7189(88)90033-x · Cited by 1,085
Recovery from psychotic illness: A 15- and 25-year international follow-up study
Harrison, G., Hopper, K. J., Craig, T., LASKA, E. M., Siegel, C., WANDERLING, J. A., Dubé, K. C., Ganev, K., Giel, R., der Heiden, W. A., et al. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.6.506 · Cited by 1,059
A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity
Hogan, T. P., Awad, A. G., & Eastwood, R. (1983) · Psychological Medicine · doi:10.1017/s0033291700050182 · Cited by 1,032
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
McEvoy, J. M., Lieberman, J. A., Stroup, T. S., Thomas, S., Meltzer, H. Y., Rosenheck, R. A., Swartz, M. S., Perkins, D. O., Keefe, R. S. E., Davis, C. E., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.4.600 · Cited by 1,013
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings
Fenton, W. S., Blyler, C. R., & HEINSSEN, R. K. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.637 · Cited by 948
Systems to rate the strength of scientific evidence.
West, S. L., King, V., Carey, T. S., Lohr, K. N., Mckoy, N. A., Sutton, S. F., & Lux, L. J. (2002) · PubMed Central · Cited by 873
Cognitive Impairment in Schizophrenia Is the Core of the Disorder
Elvevag, B., & Goldberg, T. E. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.10 · Cited by 835 · cited 2×
“…impairments in schizophrenia-spectrum disorders as well as recent paucity of research into the relationship between neurocognitive functioning and adherence behaviour (Elvevag and Goldberg, 2000; Keefe and Fenton, 2007), further exploration is necessary to reach more meaningful conclusions.”
Background
A brief method for assessing expressed emotion in relatives of psychiatric patients
Magana-Amato, A., Goldstein, M. J., Karno, M., Miklowitz, D. J., JENKINS, J. H., & Falloon, I. R. H. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90049-1 · Cited by 820
Training and quality assurance with the Brief Psychiatric Rating Scale: "The drift busters."
Ventura, J., Green, M. F., Shaner, A. L., & Liberman, R. P. (1993) · International Journal of Methods in Psychiatric Research · Cited by 748
A self‐report Insight Scale for psychosis: reliability, validity and sensitivity to change
Birchwood, M. J., Smith, J., Drury, V., Healy, J., Macmillan, F., & Slade, M. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01487.x · Cited by 695
The Expert Consensus Guideline Series
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J. L., Carpenter, D., Ross, R., & Docherty, J. P. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.7090su1cj · Cited by 692
The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia
Haro, J. M., Kamath, S., Ochoa, S., Novick, D., Rele, K., Fargas, A., Rodríguez, M. J., Rele, R., Orta, J., Kharbeng, A., et al. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.107.s416.5.x · Cited by 659
Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials
Chakos, M., Lieberman, J. A., Hoffman, E. B., Bradford, D. W., & Sheitman, B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.518 · Cited by 632
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J. L., Carpenter, D., Ross, R., & Docherty, J. P. (2009) · PubMed · Cited by 625
Reliability and validity of the delis-kaplan executive function system: An update.
DELIS, D. C., KRAMER, J. H., KAPLAN, E., & HOLDNACK, J. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704102191 · Cited by 567
Interventions to Improve Medication Adherence in Schizophrenia
Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1653 · Cited by 541
Insight in Schizophrenia. Its Relationship to Acute Psychopathology
McEvoy, J. P., Apperson, L. J., Appelbaum, P. S., Ortlip, P., Brecosky, J., Hammill, K., Geller, J. L., & Roth, L. H. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198901000-00007 · Cited by 534
Pharmacology and Therapeutics.
(1886) · The Lancet · doi:10.1016/s0140-6736(02)13327-7 · Cited by 532
The Concordance of Self-Report With Other Measures of Medication Adherence: A Summary of the Literature
Garber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E., & Lawrence, J. B. (2004) · Medical Care · doi:10.1097/01.mlr.0000129496.05898.02 · Cited by 519
Correlates and Long-Term Consequences of Poor Insight in Patients With Schizophrenia. A Systematic Review
Lincoln, T. M., Lullmann, E., & Rief, W. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm002 · Cited by 486
Client Socio-Demographic and Service Receipt Inventory – European Version: development of an instrument for international research: EPSILON Study 5
Chisholm, D., Knapp, M. R. J., Knudsen, H. C., Amaddeo, F., Gaite, L., van Wijngaarden, B., & EPSILON Study Group (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.39.s28 · Cited by 480
Integrating clinical assessment with cognitive neuroscience: Construct validation of the California Verbal Learning Test.
Delis, D. C., Freeland, J., Kramer, J. H., & Kaplan, E. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.56.1.123 · Cited by 460
Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
Novick, D., Haro, J. M., Suarez, D. L., Pérez, V., Dittmann, R., & Haddad, P. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.004 · Cited by 446
The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry
Baumann, P., Hiemke, C., Ulrich, S., Eckermann, G., Gaertner, I., Gerlach, M., Kuss, H.-J., Laux, G., Müller-Oerlinghausen, B., Rao, M. L., et al. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832687 · Cited by 425
Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
Chouinard, G., & Margolese, H. C. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.013 · Cited by 424
Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
Reynolds, G. P., & Kirk, S. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.010 · Cited by 422
Medication adherence of individuals with a first episode of psychosis
Coldham, E. L., Addington, J., & Addington, D. E. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02437.x · Cited by 422
Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol
Lieberman, J. A., Tollefson, G. D., Tohen, M. F., Green, A. I., Gur, R. E., Kahn, R. S., McEvoy, J. P., Perkins, D. O., Sharma, T., Zipursky, R. B., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1396 · Cited by 403
How should DSM-V criteria for schizophrenia include cognitive impairment?
Keefe, R. S. E., & Fenton, W. S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm046 · Cited by 394
[Schedule for Affective Disorders and Schizophrenia (SADS)].
Endicott, J., & Spitzer, R. L. (1987) · PubMed · Cited by 367
Attitudes Toward Antipsychotic Medication
Day, J. C., Bentall, R. P., Roberts, C., Randall, F., Rogers, A. E., Cattell, D., Healy, D., Rae, P., & Power, C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.717 · Cited by 364
Integrating clinical assessment with cognitive neuroscience: Construct validation of the California Verbal Learning Test.
Delis, D. C., Freeland, J., Kramer, J. H., et al. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.1.123 · Cited by 356
How often do patients with psychosis fail to adhere to treatment programmes? A systematic review
Nosè, M., Barbui, C., & Tansella, M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008328 · Cited by 353
Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs
Naber, D., Moritz, S., Lambert, M., Rajonk, F., Holzbach, R., Mass, R., Andresen, B., Frank, P., Rüdiger, H., Reinhard, M. A., et al. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00166-3 · Cited by 349
Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine
Lieberman, J. A., Phillips, M. R., Gu, H., Stroup, T. S., Zhang, P., Kong, L., Zhong-fu, J., Koch, G. G., & Hamer, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300157 · Cited by 346
The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry
Gaertner, I., Baumann, P., Hiemke, C., Ulrich, S., Eckermann, G., Gerlach, M., Kuss, H., Laux, G., Müller-Oerlinghausen, B., Ml, R., et al. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-862645 · Cited by 343
Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile
Oliver, J., Huxley, P. J., Priebe, S., & Kaiser, W. (1997) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788924 · Cited by 331
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Velligan, D. I., Lam, Y.-W. F., Glahn, D. C., Barrett, J. A., Maples, N. J., Ereshefsky, L., & Miller, A. L. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj075 · Cited by 310
A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables
Naber, D. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199509000-00017 · Cited by 309
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Morken, G., Widen, J. H., & Gråwe, R. W. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-32 · Cited by 305
Medication Adherence: A Review of the Literature and Implications for Clinical Practice
Julius, R. J., Novitsky, M. A., & Dubin, W. R. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000344917.43780.77 · Cited by 301
Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder
Robinson, D. G., Woerner, M. G., Alvir, J. M. J., Bilder, R. M., Hinrichsen, G. A., & Lieberman, J. A. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00312-7 · Cited by 290
Rezensionen
Klingberg, I. (2003) · Forum Psychotherapeutische Praxis · doi:10.1026//1616-1041.3.4.198 · Cited by 288
A two-year prospective study of treatment compliance in patients with schizophrenia
Buchanan, A. W. (1992) · Psychological Medicine · doi:10.1017/s0033291700038228 · Cited by 287
A Self-Rating Scale for Measuring Neuroleptic Side-Effects
Day, J. C., Wood, G., Dewey, M., & Bentall, R. P. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.5.650 · Cited by 285
Social class and mental illness; A community study
Pare, C. M. B. (1959) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(59)90067-4 · Cited by 269
Psychological Predictors of Insight and Compliance in Psychotic Patients
Kemp, R., & David, A. S. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.169.4.444 · Cited by 266
A new patient focused index for measuring quality of life in persons with severe and persistent mental illness
Becker, M. C., Diamond, R., & Sainfort, F. (1993) · Quality of Life Research · doi:10.1007/bf00434796 · Cited by 263
Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia
Mohamed, S., Rosenheck, R., McEvoy, J., Swartz, M., Stroup, S., & Lieberman, J. A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn067 · Cited by 258
Relationships Among Subjective and Objective Measures of Adherence to Oral Antipsychotic Medications
Velligan, D. I., Wang, M., Diamond, P. M., Glahn, D. C., Castillo, D., Bendle, S., Lam, Y. W. F., Ereshefsky, L., & Miller, A. L. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.9.1187 · Cited by 254
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
Byerly, M., Nakonezny, P. A., & Rush, A. J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.470 · Cited by 229
Insight in Schizophrenia: Involvement of Self-Reflection Networks?
van der Meer, L., de Vos, A. E., Stiekema, A. P. M., Pijnenborg, G. H. M., van Tol, M., Nolen, W. A., David, A. S., & Aleman, A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs122 · Cited by 229
A new scale (SES) to measure engagement with community mental health services
Tait, L., Birchwood, M. J., & Trower, P. (2002) · Journal of Mental Health · doi:10.1080/09638230020023570-2 · Cited by 229
Perceived social support: psychometric properties of the MSPSS in normal and pathological groups in a developing country
Eker, D., & Arkar, H. (1995) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00802040 · Cited by 226
Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder
Perkins, D. O., Gu, H., Weiden, P. J., McEvoy, J. P., Hamer, R. M., & Lieberman, J. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0114 · Cited by 220
Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study
MALLA, A. K., Norman, R. M. G., Schmitz, N., Manchanda, R., Béchard‐Evans, L., Takhar, J., & Haricharan, R. (2006) · Psychological Medicine · doi:10.1017/s0033291706007379 · Cited by 218
Medication adherence in schizophrenia
Acosta, F. J. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i5.74 · Cited by 215
Understanding delay in treatment for first-episode psychosis
Norman, R., Malla, A., Verdi, M., Hassall, L., & Fazekas, C. (2004) · Psychological Medicine · doi:10.1017/s0033291703001119 · Cited by 210
Adherence therapy for people with schizophrenia
Gray, R. J., Leese, M., Bindman, J. P., Becker, T. M., Burti, L., David, A. S., Gournay, K., Kikkert, M., Koeter, M. W. J., Puschner, B., et al. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.019489 · Cited by 194
Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade
Barkhof, E., Meijer, C. J., de Sonneville, L. M. J., Linszen, D. H., & de Haan, L. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.005 · Cited by 183
A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia
Byerly, M., Fisher, R., Whatley, K., Holland, R., Varghese, F. P., Carmody, T. J., Magouirk, B., & Rush, A. J. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.11.002 · Cited by 181
The Role of the Helping Alliance in Psychiatric Community Care
Priebe, S., & Gruyters, T. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199309000-00004 · Cited by 174
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode
Perkins, D. O., Johnson, J. L., Hamer, R. M., Zipursky, R. B., Keefe, R. S. E., Centorrhino, F., Green, A. I., Glick, I. D., Kahn, R. S., & Sharma, T. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.016 · Cited by 164
Predictors of medication adherence in patients with schizophrenia and bipolar disorder
Jónsdóttir, H., Opjordsmoen, S., Birkenaes, A. B., Simonsen, C., Engh, J. A., Ringen, P. A., Vaskinn, A., Friis, S., Sundet, K. S., & Andreassen, O. A. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01911.x · Cited by 158
Measurement of psychiatric treatment adherence
Sajatovic, M., Velligan, D. I., Weiden, P. J., Valenstein, M. M., & Ogedegbe, G. G. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.05.007 · Cited by 155
Partial Adherence to Antipsychotic Medication Impacts the Course of Illness in Patients With Schizophrenia
Masand, P. S., Roca, M., Turner, M. S., & Kane, J. M. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08r00612 · Cited by 151
Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study
Caseiro, O., Pérez‐Iglesias, R., Mata, I. F., Martínez‐García, O., Pelayo‐Terán, J. M., Tabarés‐Seisdedos, R., de la Foz, V. O., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.05.001 · Cited by 150
Utility of the health belief model in examining medication compliance among psychiatric outpatients
Kelly, G. R., Mamon, J. A., & Scott, J. E. (1987) · Social Science & Medicine · doi:10.1016/0277-9536(87)90367-4 · Cited by 146
Factors influencing compliance in schizophrenia patients.
Fleischhacker, W. W., Oehl, M., & Hummer, M. (2003) · PubMed · Cited by 146
An overview of side effects caused by typical antipsychotics.
Arana, G. W. (2000) · PubMed · Cited by 145
The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia
McCabe, R., Bullenkamp, J., Hansson, L. I., Lauber, C., Martínez‐Leal, R., Wulf Rössler, A., Salize, H. J., Svensson, B., Torres‐González, F., van den Brink, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036080 · Cited by 143
Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia
Yang, J.-W., Ko, Y., Paik, J., Lee, M., Han, C., Joe, S.-H., Jung, I., Jung, H.-G., & Kim, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.008 · Cited by 138
Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus Guidelines
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., & Docherty, J. P. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000367776.96012.ca · Cited by 134
Are we addressing the ‘right stuff’ to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication
Beck, E., Cavelti, M., Kvrgic, S., Kleim, B., & Vauth, R. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.019 · Cited by 131
Clinical correlates of early medication adherence: West London first episode schizophrenia study
Mutsatsa, S., Joyce, E. M., Hutton, S. B., Webb, E., Gibbins, H., Paul, S., & Barnes, T. R. E. (2003) · Acta Psychiatrica Scandinavica · doi:10.1046/j.0001-690x.2003.00193.x · Cited by 131
Adherence to Conventional and Atypical Antipsychotics After Hospital Discharge
Díaz, E., Neuse, E. C., Sullivan, M. C., Pearsall, R., & Woods, S. W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0311 · Cited by 126
A prospective evaluation of adherence to medication in first episode schizophrenia
Kamali, M., Kelly, B. D., Clarke, M., Browne, S., Gervin, M., Kinsella, A., Lane, A., Larkin, C., & O’Callaghan, E. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2005.05.015 · Cited by 119
Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS®) and its relationship to sociodemographic, clinical and psychopathological variables
Acosta, F. J., Bosch, E., Sarmiento, G., Juanes, N., Caballero-Hidalgo, A., & Mayans, T. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.007 · Cited by 119
The use of electronic monitoring (MEMS®) to evaluate antipsychotic compliance in outpatients with schizophrenia
Remington, G., Kwon, J. S., COLLINS, A., Laporte, D., MANN, S., & Christensen, B. K. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.015 · Cited by 118
Risperidone Nonadherence and Return of Positive Symptoms in the Early Course of Schizophrenia
Subotnik, K. L., Nuechterlein, K. H., Ventura, J., Gitlin, M. J., Marder, S. R., Mintz, J., Hellemann, G., Thornton, L. A., & Singh, I. R. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09010087 · Cited by 117
Association of Subjective Well-Being, Symptoms, and Side Effects With Compliance After 12 Months of Treatment in Schizophrenia
Karow, A., Czekalla, J., Dittmann, R., Schacht, A., Wagner, T., Lambert, M., SCHIMMELMANN, B. G., & Naber, D. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0110 · Cited by 116
Antipsychotic long-acting injections: Prescribing practice in the UK
Barnes, T. R. E., Shingleton‐Smith, A., & Paton, C. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.195.52.s37 · Cited by 114
Neurocognitive Assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project Schizophrenia Trial: Development, Methodology, and Rationale
Keefe, R. S. E., Mohs, R. C., Bilder, R. M., Harvey, P. D., Green, M. F., Meltzer, H. Y., Gold, J. M., & Sano, M. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006990 · Cited by 110
A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia
Miller, R., Ream, G. L., McCormack, J., Gunduz‐Bruce, H., Sevy, S. M., & Robinson, D. G. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.018 · Cited by 110
Overview of partial compliance.
Marder, S. R. (2003) · PubMed · Cited by 100
Early Predictors of Nonadherence to Antipsychotic Therapy in First-Episode Psychosis
Rabinovitch, M., Béchard‐Evans, L., Schmitz, N., Joober, R., & MALLA, A. K. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400106 · Cited by 99
A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia
Bhanji, N. H., Chouinard, G., & Margolese, H. C. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00109-3 · Cited by 99
Measuring the Quality of Life
Kirchman, M. (1986) · The Occupational Therapy Journal of Research · doi:10.1177/153944928600600102 · Cited by 97
The influence of therapeutic alliance and insight on medication adherence in schizophrenia
Misdrahi, D., Petit, M., Blanc, O., Bayle, F., & Llorca, P. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.598556 · Cited by 95
Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.
Weiden, P. J., & Buckley, P. F. (2007) · PubMed · Cited by 92
Psychotropic Medication Nonadherence Among United States Latinos: A Comprehensive Literature Review
Lanouette, N. M., Folsom, D. P., Sciolla, A., & Jeste, D. V. (2009) · Psychiatric Services · doi:10.1176/appi.ps.60.2.157 · Cited by 91
Norms and nurse management of conflicts: Keys to understanding nurse-physician collaboration
Keenan, G. M., Cooke, R., & Hillis, S. L. (1998) · Research in Nursing & Health · doi:10.1002/(sici)1098-240x(199802)21:1 · Cited by 84
Health beliefs and compliance with antipsychotic medication
Budd, R. J., Hughes, I. C. T., & Smith, J. A. (1996) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1996.tb01193.x · Cited by 80
Compliance therapy for schizophrenia
McIntosh, A. M., Conlon, L., Lawrie, S. M., & Stanfield, A. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003442.pub2 · Cited by 80
Staff and patient perspectives on unmet need and therapeutic alliance in community mental health services
Junghan, U. M., Leese, M., Priebe, S., & Slade, M. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037978 · Cited by 79
Adherence to antipsychotic drug treatment in early-episode schizophrenia: A six-month naturalistic follow-up study
Baloush-Kleinman, V., Levine, S. Z., Roe, D., Shnit, D., Weizman, A., & Poyurovsky, M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.030 · Cited by 78
Understanding and addressing adherence issues in schizophrenia: from theory to practice.
Weiden, P. J. (2007) · PubMed · Cited by 77
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia
Mullins, C. D., Obeidat, N. A., Cuffel, B. J., Naradzay, J., & Loebel, A. D. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.035 · Cited by 74
Becoming Adherent to Antipsychotics: A Qualitative Study of Treatment-Experienced Schizophrenia Patients
Tranulis, C., GOFF, D. C., Henderson, D. C., & Freudenreich, O. (2011) · Psychiatric Services · doi:10.1176/ps.62.8.pss6208_0888 · Cited by 73
Cost-Effectiveness of Adherence-Enhancing Interventions: A Quality Assessment of the Evidence
Elliott, R. A., Barber, N., & Horne, R. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e398 · Cited by 71
New generation antipsychotic drugs and compliance behaviour
Voruganti, L. P., Baker, L. K., & Awad, A. G. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f52851 · Cited by 67
Zur Definition, Bedeutung und Messung der Krankheitskonzepte von Patienten. Die Krankheitskonzeptskala (KK-Skala) für schizophrene Patienten
Linden, M., Nather, J., & Wilms, H.-U. (1988) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-1001215 · Cited by 63
Pharmacotherapy challenges in patients with first-episode psychosis
Abdel‐Baki, A., Ouellet‐Plamondon, C., & MALLA, A. K. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.029 · Cited by 63
Psychotropic Medication Nonadherence Among United States Latinos: A Comprehensive Literature Review
Lanouette, N. M., Folsom, D. P., Sciolla, A., & Jeste, D. V. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.2.157 · Cited by 61
An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia
Anderson, K. H., Ford, S. J. W., Robson, D., Cassis, J., Rodrigues, C., & Gray, R. J. (2010) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2010.00681.x · Cited by 60
Assessment of Medication Adherence in Patients With Schizophrenia
Kikkert, M., Barbui, C., Koeter, M. W. J., David, A. S., Leese, M., Tansella, M., Gieler, A., Puschner, B., & Schene, A. H. (2008) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31816a4346 · Cited by 58
Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons
Kim, B., Lee, S., Yang, Y. K., Park, J., & Chung, Y. (2012) · Schizophrenia Research and Treatment · doi:10.1155/2012/560836 · Cited by 55
Predictors of poor adherence to medication among patients with first‐episode schizophrenia‐spectrum disorder
le Quach, P., Mors, O. N., Christensen, T. Ø., Krarup, G., Jørgensen, P., Bertelsen, M., Jeppesen, P., Petersen, L., Thorup, A. A. E., & Nordentoft, M. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2008.00108.x · Cited by 53
Informing people with schizophrenia about their illness: The effect of residual symptoms
Smith, J., Birchwood, M. J., & Haddrell, A. (1992) · Journal of Mental Health · doi:10.3109/09638239209034512 · Cited by 49
EXPLORING THE COMPLEXITY OF COMPLIANCE IN SCHIZOPHRENIA
Pinikahana, J., Happell, B., Taylor, M., & Keks, N. A. (2002) · Issues in Mental Health Nursing · doi:10.1080/01612840290052677 · Cited by 48
A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables
Набер, Д. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199509003-00017 · Cited by 48
Systems to Rate the Strength of Scientific Evidence: Summary
West, S. L., King, V., Carey, T., Lohr, K. N., Mckoy, N. A., Sutton, S. F., & Lux, L. J. (2002) · Cited by 46
Collaboration in outpatient antipsychotic drug treatment: Analysis of potentially influencing factors
Klingberg, S., Schneider, S., Wittorf, A., Buchkremer, G., & Wiedemann, G. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.027 · Cited by 43
Methodological Challenges in Psychiatric Treatment Adherence Research
Velligan, D. I., Sajatovic, M., Valenstein, M. M., Riley, W. T., Safren, S. A., Lewis‐Fernández, R., Weiden, P. J., Ogedegbe, G. G., & Jamison, J. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.1.6 · Cited by 37
Medication adherence in schizophrenia
Roberts, D. L., & Velligan, D. I. (2011) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2011.10.001 · Cited by 30
Effects of Integrated Treatment on Antipsychotic Medication Adherence in a Randomized Trial in Recent-Onset Schizophrenia
Morken, G., Gråwe, R. W., & Widen, J. H. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0409 · Cited by 30
Is there an association between neurocognitive performance and medication adherence in first episode psychosis?
Lepage, M., Bodnar, M. D., Joober, R., & MALLA, A. K. (2010) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2010.00174.x · Cited by 22
The predictive validity of subjective adherence measures in patients with schizophrenia
Kikkert, M., Koeter, M. W. J., Dekker, J., Burti, L., Robson, D., Puschner, B., & Schene, A. H. (2011) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.335 · Cited by 20
Effect of medication-related factors on adherence in people with schizophrenia: A European multi-centre study
Meier, J., Becker, T. M., Patel, A. K., Robson, D., Schene, A. H., Kikkert, M., Barbui, C., Burti, L., & Puschner, B. (2010) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001184 · Cited by 20
A Review of Brief Medication-Adherence Instruments Used in Patients with Schizophrenia and Bipolar Disorder
Pomykacz, B., Mao, M., Roger, R. D., & Teter, C. J. (2007) · Harvard Review of Psychiatry · doi:10.1080/10673220701650383 · Cited by 19
A Validation Study of Korean-version of Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS): Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS)
Jung, H. Y., Joo, Y. H., Shin, H. K., Chung, E. K., Kang, U. G., Roh, M. S., & Kim, Y. S. (2002) · Cited by 9
Medication compliance in outpatients with schizophrenia in one veterans hospital in Taiwan
Huang, W.-F., Cheng, J.-S., Lai, I., & Hsieh, C.-F. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.2580 · Cited by 5

Research works printed but not linked: 4

Feldmann, 1995, Fragebogen zur erfassung der familienatmosphäre (fef): Einschätzung des emotionalen angehörigenverhaltens aus der sicht schizophrener patienten, Diagnostica, 41, 334
Kemp, 1996, Psychological predictors of insight and compliance in psychotic patients, British Journal of Psychiatry, 169, 444, 10.1192/bjp.169.4.444 · DOI
Kim, 2004, Assessing the reliability and validity of the korean version of the revised insight scale for psychosis (KISP), Schizophrenia Clinics, 7, 15
Weiden, 1997, The road back: working with the severely mentally ill. Medication noncompliance in schizophrenia: I. Assessment, Journal of Practical Psychiatry and Behavioral Health, 3, 106

Sorted by citations

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 615
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients
García, S., Martínez‐Cengotitabengoa, M., López-Zurbano, S., Zorrilla, E. P., López‐Mahía, P., Vieta, E., & González-Pinto, A. M. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000523 · Cited by 363
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
Velligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & Docherty, J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s124658 · Cited by 333
Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review
Ghimire, S., Castelino, R. L., Lioufas, N. M., Peterson, G. M., & Zaidi, S. T. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144119 · Cited by 227
Does relapse contribute to treatment resistance? antipsychotic response in first- vs. second-episode schizophrenia.
Takeuchi, H., Siu, C., Remington, G., Fervaha, G., Zipursky, R. B., Foussias, G., & Agid, O. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0278-3 · Cited by 200

See all 245

Authors: Sendt, K.-V., Tracy, D. K., & Bhattacharyya, S.
Affiliations: King's College London (GB)
Oxleas NHS Foundation Trust (GB)
Corresponding author: Bhattacharyya, Sagnik
ORCID: Sendt, Kyra-Verena
Tracy, Derek Kenneth
Bhattacharyya, Sagnik
Venue: Psychiatry Research
Publisher: Elsevier BV
Published: 2015-01
Volume: 225
Issue: 1-2
Pages: 14-30
ISSN: 0165-1781 (ISSN-L)
DOI: 10.1016/j.psychres.2014.11.002
OpenAlex: W2068456588
Cited by: 245
References: 156
Citations by year: 2026: 20 · 2025: 21 · 2024: 16 · 2023: 20 · 2022: 16 · 2021: 21 · 2020: 36 · 2019: 27 · 2018: 20 · 2017: 18 · 2016: 19 · 2015: 10
FWCI: 2.00
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Psychiatry Research (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: Medical Research Council, UK (MR/J012149/1)
National Institute of Health Research (NIHR) (NIHR CS-11-001)
Topics: Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords: medication adherence, antipsychotic drugs, schizophrenia spectrum disorders, treatment adherence factors, insight into illness, therapeutic relationship, social support, adverse effects, symptom severity, neurocognitive function
MeSH terms: Adult, Attitude to Health, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prospective Studies, Schizophrenia, Schizophrenic Psychology, Antipsychotic Agents, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks